Display options
Share it on

Mediators Inflamm. 1992;1(3):207-12. doi: 10.1155/S0962935192000322.

Bronchial responses to substance P after antigen challenge in the guinea-pig: in vivo and in vitro studies.

Mediators of inflammation

E Boichot, V Lagente, G L Gall, C Carré, J M Mencia-Huerta, P Braquet, A Lockhart, N Frossard

Affiliations

  1. Institut Henri Beaufour avenue des Tropiques Les Ulis 91952 France.

PMID: 18475463 PMCID: PMC2365335 DOI: 10.1155/S0962935192000322

Abstract

The effect of antigen challenge on the airway responses to substance P and on the epithelial neutral endopeptidase (NEP) activity was investigated in aerosol sensitized guinea-pigs. In vivo, bronchial responses to aerosolized substance P were similar to the responses observed in antigen-challenged guinea-pigs and in the control groups. In contrast, when the guinea-pigs were pretreated with the NEP inhibitor, phosphoramidon, a significant increase in the airway responses to substance P was observed after antigen challenge in vivo. However, in vitro, the contractile responses of the tracheal smooth muscle to substance P were similar between groups of guinea-pigs, in respect to the presence or absence of the epithelium and/or phosphoramidon. Histological studies showed an accumulation of eosinophils in the tracheal submucosa after antigen challenge and intact epithelial cells. These results show that in vivo bronchial hyperresponsiveness to substance P after antigen challenge in the guinea-pig is not associated with increased responses of the smooth muscle to exogenous SP in vitro. In addition, the results with phosphoramidon suggest that loss of NEP activity cannot account for the in vivo bronchial hyperresponsiveness to substance P presently observed.

References

  1. Am Rev Respir Dis. 1988 Jun;137(6):1432-40 - PubMed
  2. J Clin Invest. 1987 Jun;79(6):1819-25 - PubMed
  3. Prog Clin Biol Res. 1989;297:45-55; discussion 55-6 - PubMed
  4. Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):630-5 - PubMed
  5. Clin Exp Allergy. 1991 Jan;21(1):67-76 - PubMed
  6. Acta Physiol Scand. 1983 Sep;119(1):49-53 - PubMed
  7. Lancet. 1986 Feb 1;1(8475):242-5 - PubMed
  8. J Clin Invest. 1989 Sep;84(3):900-6 - PubMed
  9. J Neurocytol. 1988 Oct;17(5):583-603 - PubMed
  10. Proc Natl Acad Sci U S A. 1983 Feb;80(4):1120-4 - PubMed
  11. Am Rev Respir Dis. 1985 Apr;131(4):599-606 - PubMed
  12. J Appl Physiol (1985). 1989 Oct;67(4):1504-11 - PubMed
  13. J Pharmacol Exp Ther. 1987 Dec;243(3):1211-7 - PubMed
  14. Br J Pharmacol. 1988 Jul;94(3):675-84 - PubMed
  15. Am Rev Respir Dis. 1988 Feb;137(2):337-40 - PubMed
  16. Am Rev Respir Dis. 1985 Sep;132(3):564-8 - PubMed
  17. J Pharmacol Exp Ther. 1989 Jan;248(1):292-8 - PubMed

Publication Types